Please assess the completion status of the following clinical trial:

Trial Title: Treatment of Early Hypertension Among Persons Living With HIV in Haiti

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* PLWH 18-65 years of age~* ART duration ≥ 1 year, stable regimen ≥ 6 months~* HIV 1-RNA \< 1,000 copies/mL within past 12 months~* Pre-HTN (SBP 120-139 or DBP 80-89 mm Hg)~* No current antihypertensive treatment~* Receives HIV care at GHESKIO~* Willing to provide consent~Exclusion Criteria:~* Pregnancy~* Kidney disease or diabetes~* On protease inhibitor/ritonavir~* Advanced illness with limited life expectancy~* Plans to move out of the area within the next year~* Clinician determination that patient is unstable on ART

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Intervention (Early hypertension) (Type: EXPERIMENTAL): Participants randomized to the early HTN treatment arm will initiate 5mg daily of amlodipine immediately, increasing to 10 mg if SBP \>130 mmHg after 1 month.
- Standard of Care (Type: NO_INTERVENTION): Participants randomized to the SOC arm will not be initiated on any medications initially. They may be initiated on amlodipine only if they develop HTN (SBP ≥140 or DBP ≥90 mm Hg).

Based on this trial design, predict the completion outcome and termination type (if applicable).